What is Parkinson's Phase 2 Study Cogane (PYM50028) CONFIDENT-PD?

Category: Others

false

NCT01060878 is a phase II, randomised, double-blind, placebo-controlled study to investigate the efficacy, safety and tolerability of PYM50028 in subjects with early-stage Parkinson's Disease administered once daily for 28 Weeks.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 1

Commonly reported side effects and conditions associated with Parkinson's Phase 2 Study Cogane (PYM50028) CONFIDENT-PD

Side effect Patients

Why patients stopped taking Parkinson's Phase 2 Study Cogane (PYM50028) CONFIDENT-PD

Multiple reasons could be selected

Reason Patients
Course of treatment ended 1
See 1 patient who's stopped using Parkinson's Phase 2 Study Cogane (PYM50028) CONFIDENT-PD

Duration

Stopped using Parkinson's Phase 2 Study Cogane (PYM50028) CONFIDENT-PD

Duration Patients
6 months - 1 year 1
Adherence
Adherence Evaluations
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 1
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 0
Last updated:
There are no evaluations for Parkinson's Phase 2 Study Cogane (PYM50028) CONFIDENT-PD.